Endothelial Cells Promote Docetaxel Resistance of Prostate Cancer Cells by Inducing ERG Expression and Activating Akt/mTOR Signaling Pathway

Docetaxel is a first-line chemotherapy for the treatment of patients with castration-resistant prostate cancer (CRPC). Despite the good initial response of docetaxel, drug resistance will inevitably occur. Mechanisms underlying docetaxel resistance are not well elaborated. Endothelial cells (ECs) ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Wenhao, Su, Yiming, Zhang, Yu, Han, Bangmin, Liu, Haitao, Wang, Xiaohai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793734/
https://www.ncbi.nlm.nih.gov/pubmed/33425737
http://dx.doi.org/10.3389/fonc.2020.584505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793734/
https://www.ncbi.nlm.nih.gov/pubmed/33425737
http://dx.doi.org/10.3389/fonc.2020.584505

Ejemplares similares